🇮🇳

Index Intelligence

· daily

BSE Bankex Banking Sector Regulatory Filings — October 30, 2026

The October 30, 2026 BSE BANKEX filing batch reveals a sector in robust earnings upcycle but with divergent margin trajectories and rising credit costs. IDFC FIRST Bank posted a standout 196.5% YoY PAT jump to INR1,045 crore on 30.1% loan growth, though NIM compressed 32 bps QoQ to 5.58% with management guiding recovery to ~5.8% by Q4 FY27. Bank of Baroda delivered mixed Q2 results—PAT up 35.8% YoY to INR6,532 crore on a 95.8% non-interest income surge—but H1 FY27 PAT fell 16.5% YoY due to elevated provisions and credit cost jumped to 0.55% from 0.29%. Asset quality across both banks improved sharply (IDFC FIRST GNPA 1.32%, BoB GNPA 1.78% from 2.16%), signaling broad-based NPA resolution. Capital actions dominated the tape: Union Bank called INR3,500 crore of AT1 bonds and Canara Bank called INR1,500 crore of AT1, reflecting falling cost of capital and balance sheet optimization. Governance noise was limited to a SEBI censure on Axis Capital (no monetary penalty, no investor harm found) and routine ESOP dilution at HDFC Bank (0.03%). The key portfolio-level pattern is margin compression from excess liquidity/FCNR dilution colliding with strong loan growth—a setup that favors banks with pricing power and deposit franchise strength into H2 FY27.

1 high priority 9 medium 10 total filings
· daily

BSE Metal Sector Regulatory Filings — October 30, 2026

The India BSE METAL stream on 2026-10-30 is dominated by Q2 FY27 earnings season positioning, with Hindalco and Tata Steel scheduling calls for Nov 6-7 and Jindal Steel already delivering a mixed but volume-led print. Jindal Steel's record Q2FY27 gross revenue of INR 19,448 crores (+44% YoY) and net revenue of INR 16,704 crores (+43% YoY) on record 2.38 mt sales volume signal strong domestic demand, with 92% of volume sold domestically, but PAT slipped QoQ to INR 771 crores from INR 844 crores on higher raw material and operating costs, underscoring margin pressure despite top-line strength. Adjusted EBITDA rose 34% YoY to INR 2,504 crores, and net debt fell INR 1,141 crores to INR 14,786 crores, improving net debt-to-EBITDA to 1.51x from 1.71x, a clear deleveraging positive. Promoter group entity Jindal Power acquired 6,06,053 shares (0.059%) on October 28, 2026, lifting its stake to 1.274%, a modest but sentiment-supportive insider buy. Meanwhile, Hindalco and Tata Steel filings are routine earnings-call intimations with no financial data, creating a two-day catalyst window (Nov 6-7) that will set the tone for the sector. The key cross-cutting theme is volume-driven revenue growth colliding with cost inflation, with balance sheet repair (Jindal Steel) and upcoming management commentary (Hindalco, Tata Steel) as the swing factors for the metal index.

4 medium 4 total filings
· daily

BSE Auto Sector Regulatory Filings — October 30, 2026

The India BSE AUTO stream on 2026-10-30 is dominated by Tata Motors' transformational €14.4/share cash tender for Iveco Group, acquiring ~89.42% for ~€3.4bn, making Iveco an indirect subsidiary. However, Iveco's revenue has declined for three consecutive years (CY23: ₹1,69,527 Cr; CY24: ₹1,52,964 Cr; CY25: ₹1,42,471 Cr), raising integration and value-creation risks. The Q2 FY27 earnings season kicks off with Tata Motors PV (Nov 13), Samvardhana Motherson (Nov 5), and Balkrishna Industries (Nov 4, with potential 2nd interim dividend). Insider activity is limited to a vague SAST disclosure for Sona BLW by ICICI Prudential MF, with no transaction details. Capital allocation signals are mixed: Balkrishna's dividend consideration vs. Bharat Forge's ₹403 Cr downstream investment in subsidiaries. Overall, the sector is in a consolidation and portfolio-restructuring phase, with near-term catalysts from earnings and dividend announcements.

3 high priority 5 medium 8 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 30, 2026

The India BSE FMCG stream on 2026-10-30 is dominated by Varun Beverages' Q3 CY2026 print, which shows strong 33.3% YoY revenue growth to ₹68,155.86 mn but a sharp 334 bps gross margin contraction to 53.1% and 140 bps EBITDA margin decline to 21.6%, with PAT growth of 13.5% lagging revenue. Sequential declines of 22.1% in revenue and 45.0% in PAT reflect expected seasonality but also highlight cost pressures from packaging and geopolitical supply disruptions. The company completed two acquisitions (Twizza ZAR 2,053 mn and Kenya USD 32 mn) while the Crickley Dairy deal moved to arbitration, signaling an aggressive but risky international expansion strategy. Emami promoter entities showed mixed encumbrance activity—one release of 0.96% and one fresh pledge of 0.50%—net reducing pledged shares slightly. United Spirits disclosed a 10-day GST/VAT search by Maharashtra authorities, a negative governance event with potential overhang. Colgate-Palmolive initiated a postal ballot for a new MD & CEO, and Hindustan Unilever will participate in Unilever's Capital Markets Day on Nov 4, a potential catalyst. Overall, the sector shows volume-led growth for Varun but margin erosion, stable governance at Colgate, and regulatory noise at United Spirits.

3 high priority 8 medium 11 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 30, 2026

The India BSE Pharma stream on 2026-10-30 is dominated by Q2 FY27 earnings, with 13 new filings across Max Healthcare, Mankind, Sun Pharma, Cipla, Alkem and Zydus. A clear sector pattern is emerging: revenue growth is healthy (Max +20.3% YoY, Mankind +17.3%, Sun +11.9%, Cipla +4% QoQ) but profit quality is diverging sharply due to one-offs, tax effects and margin pressure. Max Healthcare's consolidated PAT fell 15.6% YoY despite 20.3% revenue growth, as expenses rose 20.1% and finance costs jumped 37%; H1 PAT growth of 7% lagged H1 revenue growth of 18%. Sun Pharma's PAT collapsed 36.2% YoY on ₹12,688.3 Million exceptional items, though pre-exceptional PBT rose 6.3%. Mankind stands out with EBITDA +27.2% and PAT +37.7%, aided by 33% international growth and improving volume trajectory (6.2% in Q2 vs 0.5% in FY25). Cipla showed sequential margin recovery (+200 bps QoQ to 18.7%) but faces a US FDA Form 483 with 7 observations at Pithampur. Regulatory news was mixed: Alkem's Mandva API facility received a clean US FDA inspection (no Form 483), while Sun Pharma won US FDA approval for ILUMYA in psoriatic arthritis. Capital allocation remains growth-heavy: Max approved ₹415 Cr capex for 209 brownfield beds and revised its Gurugram project cost upward to ₹1,143 Cr with completion delayed to April 2027. Insider/ESOP activity was routine and non-material (Max allotted 16,803 shares at ₹350 and granted 95,000 options at ₹800). Overall, the sector shows top-line resilience but earnings quality and margin sustainability are key differentiators; we flag Max's margin compression and Sun's exceptional-item volatility as near-term risks while highlighting Mankind's volume-led beat and Cipla's margin recovery as opportunities.

3 high priority 12 medium 15 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — October 30, 2026

The India BSE REALTY digest for 30-Oct-2026 is dominated by Q2/H1 FY27 earnings from three index heavyweights — Lodha Developers, The Phoenix Mills, and Aditya Birla Real Estate — alongside routine investor-meet and compliance notices from Anant Raj and Brigade Enterprises. The overarching theme is a sharp divergence between H1 strength and Q2 sequential deceleration: Lodha's H1 FY27 revenue rose 29.8% YoY to ₹94,641 mn and PAT jumped 62.9% to ₹23,866 mn, yet Q2 revenue fell 10.6% QoQ and PAT dropped 26.2% QoQ with operating margin compressing to 36.12% from 43.11%. Phoenix Mills showed the same pattern — H1 revenue +7.7% and PAT +16.5% YoY, but Q2 consolidated revenue grew only 3.4% YoY as its Residential segment collapsed 65.2% YoY to ₹6,075.59 Lakh, offset by a 16.1% YoY rise in Property & Related Services. Aditya Birla Real Estate delivered explosive income growth (Q2 total income +755% YoY to ₹268 cr, H1 +309% to ₹355 cr) but shocked with Q2 presales of only ₹298 cr and a deferral of the Worli Tower C launch to Q2 FY28, explicitly guiding FY27 presales below last year's ₹8,000 cr. Portfolio-level signals are mixed-to-positive on balance sheet quality (Lodha net D/E 0.21x vs 0.5x ceiling, cost of debt stable at 7.8%; ABREL net debt-free) but negative on near-term sales momentum and margin trajectory. The most critical actionable development is ABREL's guidance cut and launch deferral, which contrasts with Lodha's H1 pre-sales already covering >40% of full-year guidance. Insider activity was absent across all filings, and capital allocation disclosures were limited to routine Company Secretary transition at Lodha. Investors should rotate toward annuity-heavy, balance-sheet-light names (Phoenix Mills' retail/office annuity grew 16% revenue and 21% EBITDA) while monitoring residential presales risk at ABREL and margin sustainability at Lodha.

4 high priority 8 medium 12 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 30, 2026

The October 30, 2026 India BSE IT filing stream is dominated by routine compliance and event-scheduling disclosures rather than hard financial results, with all four filings carrying neutral sentiment and materiality scores of 2-4/10. The most substantive development is Infosys's inauguration of a 1.1 million sq. ft. Software Development Block at its Pocharam, Hyderabad campus, adding 10,000 seats and capacity for 13,000+ employees — a tangible signal of medium-term demand confidence and continued hybrid-delivery expansion in BFSI, Retail, Life Sciences and Manufacturing. Sonata Software's twin filings confirm a Q2/H1 FY27 board meeting on November 5, 2026 and an earnings call on November 6, 2026, with the board also considering a second interim dividend for FY 2026-27 — making Sonata the first capital-allocation catalyst in this cycle. Hexaware's Regulation 47 newspaper publication confirms Q2 and nine-month FY27 results are already public, but the filing itself carries no extractable financials, limiting comparability. Across the stream there are no period-over-period financial comparisons, no insider transactions, no guidance changes and no transaction details in the enriched data, so the digest is necessarily catalyst- and capacity-driven rather than earnings-driven. The key near-term market implication is a compressed event window: Sonata's results and dividend decision on November 5-6 will be the first hard read on mid-cap IT demand and shareholder-return posture this quarter.

4 medium 4 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 30, 2026

The 18 filings are dominated by Reliance Industries' record Q2 FY27 (revenue +28.6% YoY, PAT +32.1% YoY) and the Jio Platforms IPO, which together reset the earnings trajectory for the index's largest constituent, while Sun Pharma and Bharat Electronics show a common pattern of strong topline growth with margin/profit quality strain. Sun Pharma's revenue rose 11.9% YoY but PAT fell 36.2% on ₹12,688 million of exceptional items, and BEL's revenue grew 26.0% while PAT grew only 14.8%, signaling margin compression. Reliance's consolidated EBITDA margin contracted 60 bps YoY to 17.2% and Retail EBITDA fell 10.2% YoY, offsetting O2C (+67.9%) and Digital Services (+17.7%) strength. Capital allocation remains active: Bajaj Finance raised ₹2,069.5 crore via 8.70% NCDs, Reliance raised ₹12,000 crore in NCDs and ₹30,188 crore via the Jio IPO, and HDFC Bank's ESOP allotment was negligible (0.03% dilution). Regulatory and governance items (SEBI censure on Axis Capital, Sun Pharma auditor rotation, Power Grid director appointment) are low-materiality but worth monitoring. Overall, the portfolio shows robust revenue momentum but widening dispersion in profit quality and margin trends, with upcoming earnings calls (Tata Steel Nov 7, HUL Capital Markets Day Nov 4) as near-term catalysts.

4 high priority 14 medium 18 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 29, 2026

Eight filings dated 29 October 2026 cover BSE BANKEX constituents, but the enriched fields (period-over-period comparisons, forward-looking guidance, insider activity, capital allocation, transaction and ratio data) are absent from every filing as supplied; the filings contain only summaries, key points and sentiment/materiality tags. No quantified YoY or QoQ trends, margins, NIM, insider transactions or guidance can therefore be drawn, and any such claim would be fabricated. What the filings do establish is a regulatory-compliance theme: RBI penalties hit Punjab National Bank (Rs 1.57 crore, Currency Chest operational guidelines) and Canara Bank (Rs 7.3 lakh across ATM cashout violations in Karnataka and Tamil Nadu), both immaterial in scale. Bank of Baroda faces an unresolved litigation overhang from Dr BR Shetty's interim applications in the Bombay High Court, which the bank says it has not been served with and which it frames as selective media dissemination ahead of quarterly results. IndusInd Bank made its on-schedule Rs 227.08 crore Tier 2 coupon payment, a routine credit-positive event. State Bank of India and three Yes Bank investor-conference notices are administrative, with Yes Bank's November 16-27 meeting slate offering the only dated catalysts in the set.

8 medium 8 total filings
· daily

BSE Metal Sector Regulatory Filings — October 29, 2026

Across the 11 filings for the India BSE METAL stream dated 2026-10-29, the dominant theme is an active Q2 FY27 earnings season among metal constituents, with several companies (Vedanta, JSW Steel, Hindalco/Novelis, Lloyds Metals, APL Apollo) disclosing call logistics or transcripts that carry the substantive numbers outside the filings themselves. The only filings with hard quantitative content are APL Apollo Tubes (record Q2 volume of 960,000 tons and EBITDA per ton of Rs. 6000, with FY27 EBITDA guidance above Rs. 2200 crore) and Lloyds Metals (USD 130 million SOFR+450 secured notes plus a Crisil AA/Stable reaffirmation and two fresh NCD assignments totalling Rs. 6,450 crore of rated NCDs). Period-over-period comparisons are largely absent in the enriched data for this batch, so trend synthesis is limited; the clearest directional read is APL Apollo's record quarter offset by export and Dubai disruption. Lloyds Metals is the most active issuer in the batch, with a debt-funded growth profile (new secured USD notes, rating reaffirmation, and a board meeting on 03 November 2026 to consider a fundraise), which concentrates both the catalyst flow and the leverage question. Adani Enterprises' two Monitoring Agency reports show no deviation from stated use of proceeds (Rs. 24,930.30 crore rights issue and Rs. 15,000 crore QIP), which is a clean governance signal. Promoter activity at Jindal Steel (Jindal Power's routine 0.034% purchase) is immaterial. Overall the batch leans neutral with a positive credit signal and one mixed operating update.

2 high priority 9 medium 11 total filings
· daily

BSE Auto Sector Regulatory Filings — October 29, 2026

Across the 11 filings for the S&P BSE AUTO stream dated 2026-10-29, the majority are administrative or procedural (analyst meet schedules, audio recordings, UPSI code updates, a product launch), with only two carrying hard financial data. The clearest quantitative signal comes from Schaeffler India, whose Q3 CY26 presentation shows top-line strength (standalone revenue up 27.4% YoY to Rs 30,058 mn and 12.1% QoQ; 9M revenue up 21.4% YoY) undermined by weaker earnings quality: EBITDA margin fell to 18.7% from 20.2% YoY and free cash flow dropped 81.7% YoY to Rs 408 mn on higher working capital and Rs 1,822 mn of capex. Maruti Suzuki's EV export milestone (cumulative shipments above 50,000 units, roughly 93% of India's electric passenger vehicle exports in April-September 2026 and over 50% of passenger vehicle exports) is the most positive operating development, anchored by the 1 million-unit Hansalpur capacity. Bajaj Auto disclosed three upcoming investor events (16 November, 17 November, 2 December), which signals active investor engagement but no new numbers. Bharat Forge's Q2/H1 FY27 results call on 5 November 2026 is the nearest hard catalyst in the set. Samvardhana Motherson's EUR 75 mn guarantee for a wholly owned subsidiary is immaterial to consolidated numbers but notable as a financing-structure disclosure. No insider trading, dividend, buyback, or M&A valuation data was present in the enriched fields for these filings, so conviction signals rely on operating disclosures rather than insider behaviour.

11 medium 11 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 29, 2026

Ten filings were reviewed for the India BSE FMCG stream on 2026-10-29. Nine are new filings and one is context. Eight filings concern Godrej Consumer Products (GCPL), Tata Consumer Products, United Spirits and Radico Khaitan; two (United Spirits and Radico Khaitan) are admin or meeting notices with no financials. The dominant theme is a widening gap between strong consolidated top-line growth and softer standalone profitability: GCPL consolidated revenue rose 19.0% YoY to ₹4,413.09 Cr and consolidated PAT rose 13.9% to ₹522.92 Cr, yet standalone PAT fell 5.3% YoY to ₹337.33 Cr and standalone operating margin contracted to 21.4% from 22.5%. Input-cost inflation (LPG, tea, salt) and a ~150 bps trade inventory correction are compressing margins across the sector. Tata Consumer's India tea/coffee revenue fell 1% with flat volumes, while its growth businesses rose 40%. GCPL's Q2 consolidated profit was partly supported by exceptional items, and its Latin America & Others EBITDA margin fell to 0.9%. The interim dividend of ₹5/share (record date November 4, 2026, payment by November 27, 2026) and reiterated FY27 guidance are the main near-term catalysts. No insider transactions, pledges, or M&A were disclosed in these filings.

4 high priority 6 medium 10 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 29, 2026

Three filings dated 29 October 2026 (with one earlier-context Torrent filing) form a thin, mostly administrative digest for the S&P BSE PHARMA constituent set. The most material development is Mankind Pharma's CRISIL action: the AA+/Stable rating was reaffirmed on ₹2,500 crore of NCDs (₹400 crore and ₹2,100 crore tranches), while the ₹2,500 crore NCD rating and ₹1,500 crore A1+ commercial paper rating were withdrawn, with no reason disclosed in the filing itself. Biocon's No. 13 ranking among Science's Top 20 Global Employers is a reputational positive with no financial content. Torrent's Regulation 30(6) intimation points to a Q2/H1 FY2026-27 earnings call transcript, but the substantive numbers are not in the provided material, so no period-over-period comparisons can be extracted. No insider trading, dividend, buyback, M&A, or guidance data appears in any filing, which limits quantitative synthesis. The key analytical gap is that the withdrawal rationale must be obtained from CRISIL's rationale document before drawing conclusions about Mankind's credit profile.

1 high priority 2 medium 3 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — October 29, 2026

All five filings relate to a single S&P BSE REALTY constituent, Brigade Enterprises Limited, so this digest is a deep read on one company rather than a sector sweep. The quarter ended 30 September 2026 shows a clear divergence: top-line revenue contracted (consolidated revenue from operations down 13.5% YoY to Rs 1,19,636 lakh; H1 FY27 revenue down about 12%), while profitability expanded sharply (consolidated profit for the quarter up 28.5% to Rs 21,882 lakh; standalone PAT more than doubled to Rs 11,449 lakh). The profit improvement is driven largely by a 38.5% YoY fall in land purchase costs (to Rs 52,518 lakh from Rs 85,441 lakh) and a shift in revenue mix, rather than by volume growth. Sales momentum is mixed: Q2 FY27 pre-sales of Rs 1,827 Cr were up 72% QoQ but down 10% YoY, with H1 pre-sales down 8% YoY, and residential was the bright spot while commercial pre-sales fell 49% YoY. Annuity and hospitality segments are a stabilising feature, with leasing at 90% occupancy and hospitality RevPAR up 10% YoY to Rs 5,922. Governance and capital activity is routine: an unmodified auditor review and a new Rs 525 ESOP grant at a 2.48% discount to the prior close. The key market question is whether margin gains are sustainable as the top line keeps shrinking.

3 high priority 2 medium 5 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 29, 2026

Five filings from S&P BSE IT constituents were reviewed for 29 October 2026, but the enriched data fields (period-over-period comparisons, forward-looking guidance, insider activity, capital allocation, and transaction valuations) are essentially empty across all of them. The filings themselves are largely administrative or product-oriented: Hexaware's board-approved results lack headline revenue or profit figures in the body of the filing, Wipro completed a 20% stake acquisition in FLARRE.AI ahead of schedule, Zensar published its Q2FY27 earnings call recording, Coforge launched an AI-native Autonomous Software Factory operating model, and Infosys Finacle announced banking innovation awards. Because no period-over-period revenue, margin, or guidance figures are supplied, no quantitative trend analysis across the portfolio is possible, and this digest does not infer financial performance that the filings do not disclose. The most material item is Hexaware's governance overhaul, including a CEO transition from R Srikrishna to Vivek Jetley, board resignations, and entity rationalization via slump sale and mergers, which warrants attention pending the annexures. Sentiment is mixed-to-neutral overall, with positive tones attached to Coforge and Infosys product and recognition news. Investors should obtain Hexaware's enclosed results annexures and Zensar's recorded call before drawing any valuation conclusions.

5 medium 5 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 29, 2026

Across the 23 filings for the SENSEX 30 stream (period 29 Oct 2026), the dominant theme is top-line growth coexisting with sharp margin pressure from input-cost inflation and currency weakness. Asian Paints posted Q2 FY27 consolidated revenue of ₹9,953.89 Cr (+16.9% YoY) and standalone PAT of ₹1,095.55 Cr (+14.6% YoY), yet consolidated PBDIT margin fell 202 bps to 15.6% and standalone profit fell 25.9% QoQ as cost of materials rose about 35% YoY. InterGlobe Aviation (IndiGo) illustrates the same squeeze in a more extreme form: revenue rose 25.9% YoY to INR 233,638 Mn, but fuel CASK rose 68.9%, the rupee depreciated about 9.2% (USD/INR average 95.09 vs 87.06), and the net loss before forex widened to INR 7,237 Mn from a profit of INR 1,039 Mn. Trent delivered solid YoY growth (standalone revenue +22.5%, net profit +8.6%), but its Debt Service Coverage Ratio fell to 1.38 from 2.85 and inventories rose about 24% versus March 2026, a watch-worthy working-capital signal. Governance news was concentrated at Trent, where Chairman Noel N. Tata retires effective 11 November 2026 and Bahram Vakil takes over from 12 November. Remaining filings (NTPC BESS commissioning, Maruti EV export milestone, SBI investor meet, Reliance and Infosys routine notices) were operational or low-materiality. Net read: headline growth is intact, but earnings quality and margin resilience across consumer and aviation names deserve closer scrutiny than top-line prints suggest.

9 high priority 14 medium 23 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 28, 2026

Both filings concern BSE BANKEX constituents: Punjab National Bank (PNB) reported Q2 FY27 standalone net profit of Rs 553,223 lakh, up 12.8% YoY, with half-year profit up 63.9%, and gross NPA improved to 2.55% from 3.45%, though quarter-on-quarter profit growth slowed to 5.3%. AU Small Finance Bank reported Q2 FY27 PAT of INR858 Cr (up 53% YoY), deposits up 29% YoY and loans up 25% YoY, but flagged sequential margin compression of 9 bps to 5.8% and a rising-rate environment that could cap cost-of-funds gains. Both banks show strong year-on-year earnings momentum, but both reports carry mixed signals: PNB's headline profit is flattered by a one-off Rs 4,143.55 crore Investment Fluctuation Reserve transfer and falling other income (-17.1% YoY), while AU SFB faces sequential margin pressure and regulatory fee-income headwinds. The common theme is that asset-quality improvement and credit growth are supporting earnings, while treasury income weakness and rate-cycle risk are the main offsets. Neither filing contains insider transaction, dividend, buyback, or explicit forward-guidance data, so conviction signals are limited to reported operating metrics.

2 medium 2 total filings
· daily

BSE Metal Sector Regulatory Filings — October 28, 2026

The BSE METAL stream for 28 October 2026 is dominated by Q2 FY27 results from Vedanta and Adani Enterprises, both reported with mixed sentiment because headline growth coexists with sharply weaker bottom lines. Vedanta posted record consolidated revenue of Rs 25,812-26,356 crore (up 57% YoY), EBITDA up 106% YoY and PAT of Rs 6,202 crore (up 151% YoY), with net debt falling Rs 4,624 crore QoQ to Rs 3,675 crore (Net Debt/EBITDA 0.1x), yet Copper International sales fell 74% YoY and standalone posted a loss of Rs 170 crore, with comparability distorted by the 1 May 2026 demerger. Adani Enterprises reported H1 consolidated revenue of Rs 71,569 crore (up 62% YoY) and record H1 EBITDA of Rs 11,958 crore (up 56% YoY), but consolidated PAT fell sharply (Q2 down 64% to Rs 1,221 crore on the filing's basis; H1 turned negative) after the Rs 2,644 crore OFAC settlement, and AEL's credit rating was upgraded to AA/Stable. Capital-structure signals are constructive across the group, including Vedanta's interim dividend of Rs 5 per share and Adani's Rs 15,000 crore QIP and Rs 24,907 crore rights issue with largely on-track utilisation. Administrative and governance filings from SAIL, NALCO, Lloyds Metals and Vedanta's ESOS grant add little quantitative content but flag new government nominee directors at SAIL and a USD 130 million secured note at Lloyds.

4 high priority 15 medium 19 total filings
· daily

BSE Auto Sector Regulatory Filings — October 28, 2026

Across the 21 BSE AUTO filings dated 28 October 2026, the dominant theme is a sharp divergence between top-line momentum and profitability. Hero MotoCorp (standalone revenue +21% YoY, PAT +5%, EBITDA margin flat at 13.4%), Hyundai Motor India (revenue +18.3% YoY, standalone PAT -24.3%, consolidated EBITDA margin down to 9.5% from 13.9%) and TVS Motor (revenue +44% YoY, but leverage rising sharply at standalone net debt/equity 0.37x vs 0.25x) all show volume-led growth being absorbed by commodity and operating cost inflation. TVS Motor delivered the strongest headline print (record 1.9 million units, PAT +52%), yet its EBITDA margin expanded only 30 bps and sequential NBFC profit fell. Corporate-structure activity dominates the governance stream: TVS Motor's composite scheme (demerger of the consumer finance business, roughly 11% of turnover) and the Rs. 530 Cr STPL acquisition, plus Hero's Rs. 300 Cr investment in its Netherlands holding, signal active portfolio restructuring. Market implication: headline growth is being rewarded less than margin durability, and investors should differentiate between volume beneficiaries and cost-exposed names while tracking the EPR/ELV regulatory overhang that Hero has flagged as unquantified.

11 high priority 10 medium 21 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 28, 2026

Across the 14 filings for the BSE FMCG stream dated 28 October 2026, the dominant story is a sharp divergence between top-line momentum and margin/profit quality. Hindustan Unilever (HUL) delivered its strongest Underlying Sales Growth in 14 quarters (USG 15%, UVG 7%, Turnover Rs 18,071 Cr), yet EBITDA margin contracted 140 bps YoY to 22.6% and reported PAT was flat at Rs 2,796 Cr because the prior-year base carried a Rs 273 Cr one-off tax gain; PAT before exceptional items grew 9%. United Spirits (USL) showed similar mixed prints: Q2 FY27 standalone NSV grew 2.8% and H1 NSV 4.2%, but Q2 EBITDA fell 4.3% with margin down 146 bps to 19.7%, while the Popular segment's NSV dropped 22.7% on Maharashtra MML and Karnataka excise changes. Consolidated USL profit was pressured by a Rs 32 Cr loss from the Sports (RCSPL) business reclassified as discontinued operations, pending BCCI approval of the sale, which is expected within 12 months. Portfolio-level pattern: top-line growth is being bought through price/mix and A&P rather than volume, with cost pressure from West Asia and rising advertising intensity compressing margins. Emami's filing is administrative only, and the remaining HUL and USL governance and personnel filings are routine, so the market-moving content is concentrated in HUL's Q2 print, the USL segment disclosures, and the pending RCSPL sale.

5 high priority 9 medium 14 total filings